HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
Social Media
Monetate Announces Company Expansion and 49% QoQ Sales Growth
Data reveals social media driving purchases and substantially higher AOV; Monetate announces key enhancements to…
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS
FDA granted accelerated approval of QALSODY based on a reduction of neurofilament, a marker of…
American Cleaning Institute: Unsafe Cleaning Storage Trends Rampant on Instagram, TikTok & Pinterest
New Research Shows Nearly 800,000 Posts Promoting Laundry Packets Storage Outside Original Containers Over Four-Year…
Alcoa Corporation Reports First Quarter 2023 Results
PITTSBURGH–(BUSINESS WIRE)–Alcoa Corporation (NYSE: AA) today reported first quarter 2023 results that included sequential improvements…
New Report Supported by Hundreds of Security Leaders Uncovers Enterprise Risks and Opportunities of Generative AI
“We face a historic opportunity to affect regulation, security, privacy, and safety of millions around…
Windstream Enterprise and Talkdesk Partner to Deliver AI-Powered CCaaS Solution
Talkdesk’s intelligent, cloud-based contact center capabilities plus Windstream Enterprise’s managed services give enterprises all the…
Qualtrics Secures Highest Rating Among Experience Management Providers in G2’s Spring 2023 Enterprise Grid® Report
G2 Buyers recognized Qualtrics as the top provider for Experience Management and Feedback Analytics Qualtrics…
Amarin to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023
DUBLIN, Ireland and BRIDGEWATER, N.J., April 19, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:…
Amarin to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023
DUBLIN, Ireland and BRIDGEWATER, N.J., April 19, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:…
Award-Winning Photographer Jeremy Cowart Presents AURAS, a First-of-its-Kind Live Performance Art Event Taking Place at Vū Nashville on May 2, 2023
AURAS Will Leverage Kaleidoscope, Transient Labs’ Image Processing Library, to Help Create 10k Unique NFTs…
FOX NEWS DIGITAL FINISHES THE FIRST QUARTER OF 2023 AS THE TOP NEWS BRAND WITH MULTIPLATFORM VIEWS AND MINUTES
FOX News Digital Sees 28 Percent Year-Over-Year Growth with Unique Visitors Following Homepage Refresh FOX…
Dine Brands Global, Inc. Completes Refinancing of its Class A-2-I Senior Secured Notes Through a Securitization
GLENDALE, Calif.–(BUSINESS WIRE)–Dine Brands Global, Inc. (NYSE: DIN) (“Dine Brands” or the “Corporation”), the parent…
Cogent Biosciences Presents Preclinical Data at AACR Annual Meeting Highlighting Precision Therapy Pipeline and Announces Initiation of Part 2 of the Registration-Enabling APEX Trial with Bezuclastinib in Advanced Systemic Mastocytosis
Preclinical data describes a novel EGFR-sparing, brain-penetrant ErbB2 inhibitor active against key oncogenic ErbB2 mutations…
Cogent Biosciences Presents Preclinical Data at AACR Annual Meeting Highlighting Precision Therapy Pipeline and Announces Initiation of Part 2 of the Registration-Enabling APEX Trial with Bezuclastinib in Advanced Systemic Mastocytosis
Preclinical data describes a novel EGFR-sparing, brain-penetrant ErbB2 inhibitor active against key oncogenic ErbB2 mutations…
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
– Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains…
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
– Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains…
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
New subgroup data and further analyses of the aflibercept 8 mg clinical trial program to…
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
New subgroup data and further analyses of the aflibercept 8 mg clinical trial program to…
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…